Dr Glenn Cruse

Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, NC, USA

Dr. Glenn Cruse, is an Associate Professor of Immunology at North Carolina State University, Raleigh, N.C. Dr. Cruse graduated with a Bachelor’s of Science degree with the highest honor in Biomedical Science from DeMontfort University, Leicester, UK. He completed his Ph.D. graduate studies in Infection, Immunity and Inflammation at Glenfield Hospital, of the University of Leicester, U.K. Dr. Cruse then moved to Bethesda, M.D. U.S.A., as a visiting postdoctoral fellow in the Laboratory of Allergic Diseases, NIAID at the National Institutes of Health (NIH). In 2016, Dr. Cruse joined North Carolina State University, Raleigh, N.C. as an Assistant Professor, and was promoted to Associate Professor with tenure in 2023. Dr. Cruse is a recipient of the NC State University Faculty Scholar award, the NC State University Goodnight Early Innovator award and an NIH Director’s award.

Dr. Cruse runs an NIH- and industry-supported research program aiming to establish novel regulators of allergic inflammation and develop targeted therapeutics for asthma and allergic inflammatory diseases as well as mast cell neoplasia and other mast cell-mediated diseases. Dr. Cruse has authored and co-authored ~50 publications including articles in top journals such as the New England Journal of Medicine, Proceedings of the National Academy of Sciences USA and Immunity. Dr. Cruse has multiple awarded and pending patent applications for therapeutics development. He also serves as an Associate Editor at Frontiers in Immunology and has actively served to review grants for several NIH review panels for more than 8 years.

Updated 10 April 2025